Search

Acute Lymphocytic Leukemia: impressive results with the monoclonal antibody blinatumomab

The Phase 2 dose-ranging study MT103-206 evaluated the efficacy, safety and tolerability of blinatumomab in adult patients with B-precursor Acute Lymphoblastic Leukemia who had relapsed following treatment with standard front-line chemotherapy or allogeneic stem cell transplant.

Read more

“Follow your dreams! Go for it!” – Verena Gaidzik, woman in hematology/EHA volunteer

Verena Gaidzik is a physician scientist in the department of Internal Medicine III (Head: Prof. Dr. Hartmut Döhner) at the University Hospital of Ulm. She has board certifications in internal medicine, hematology and oncology as well as palliative medicine.

Read more

Navigate hematology

Building a career and a professional network can be overwhelming! Which career path should you take? How can you establish a meaningful mentoring relationship? Which funding is available and right for you? Who can you collaborate with? Is it time to publish?

On…

Read more

EHA Research Conference

On this page, you can browse and/or download the interactive ReCon Meetings Sponsor Program. EHA is proud to announce the third edition of the EHA Research Conference, titled "Transcriptional control and chromatin alterations in normal and abnormal hematopoiesis".

Read more

Meet Eva Hellström-Lindberg, our Volunteer of the Month

Can you tell us what you do for EHA and when you started?
These days I am not as involved in EHA as I used to be, besides the various services when asked for, which I think is how it should…

Read more